Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on April 2, 2025
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
GlobeNewswire
·
April 2, 2025
PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange …
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
GlobeNewswire
·
April 2, 2025
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the …
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. FibroGen’s management team will be …
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
GlobeNewswire
·
April 2, 2025
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase …
GRI Bio Announces Closing of $5.0 Million Public Offering
GlobeNewswire
·
April 2, 2025
LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
GlobeNewswire
·
April 2, 2025
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial …
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
GlobeNewswire
·
April 2, 2025
Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential …
NeuroPace Announces Refocusing of Product Portfolio
GlobeNewswire
·
April 2, 2025
-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by the end of 2027 and Achievement of 20%+ Revenue CAGR -- …
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
April 2, 2025
FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
GlobeNewswire
·
April 2, 2025
Introduction of EluPro at Heart Rhythm 2025 in San Diego, April 25-27, 2025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, is proud to announce …
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14
GlobeNewswire
·
April 2, 2025
KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on …
BioCryst to Present at Upcoming Investor Conference
GlobeNewswire
·
April 2, 2025
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 9:30 a …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Marketstrat launches Markintel™ Methodology & Frameworks for Actionable Insights in MedTech & Healthcare
EIN Presswire
·
April 2, 2025
Markintel™ suite delivers evolving market intelligence for data-driven sectors, bridging insight gaps with actionable frameworks …
Enamine and ChemPass Collaborate to Accelerate Hit Discovery
EIN Presswire
·
April 2, 2025
KYIV, UKRAINE, April 2, 2025 /EINPresswire.com/ -- Enamine, the leading provider of chemical compounds and drug discovery services, and ChemPass, a contract research organization for computational and AI-assisted software, today announced their start of …
Inc. Names InTouch Med Supply to Its 2025 List of the Fastest-Growing Private Companies in the Northeast
EIN Presswire
·
April 2, 2025
Companies on the Inc. Regionals: Northeast list had a median growth rate of 100 percent. KING OF PRUSSIA, PA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders …
Mitolyn WARNING (DOCTOR-APPROVED RESEARCH): The Metabolic Reset Formula Changing How Experts See Fat Loss
GlobeNewswire
·
April 2, 2025
SEATTLE, WA, April 02, 2025 (GLOBE NEWSWIRE) -- Mitolyn In a world where weight loss solutions come and go, Mitolyn has emerged as a frontrunner, capturing the attention of thousands looking for a sustainable, science-backed approach to shedding excess …
ABL Diagnostics Signs Exclusive Distribution Agreement with Genient to Expand Microbiology Genotyping in India
EIN Presswire
·
April 2, 2025
WOIPPY, FRANCE, April 2, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. (https …